Navigation Links
Researchers aim to prevent global prematurity and stillbirths
Date:2/18/2008

ing infant and maternal health throughout the developing world and right here at home.

We believe it is our responsibility to help solve this global problem and have committed the resources to form a new office at Childrens to specifically address prematurity and stillbirths, continued Hansen. The office will be directed by Dr. Craig Rubens, professor of pediatrics at the University of Washington School of Medicine, and will be based at the hospital and closely linked to our Research Institute.

Over 500,000 babies are born prematurely in the U.S. each year. In 2004, 1 of 8 babies was born prematurely and between 1994 and 2004 the rate of infants born prematurely in the U.S. climbed nearly 14 percent, according to the National Center for Health Statistics. Prematurity rates are growing in Latin America as well.

Bringing together the research literature and the worlds leading stillbirth and prematurity scientists will allow us to build a critical research agenda for the future. This is an area in medicine that has yet to receive the funding levels and attention it needs, said the grants principal investigator Craig Rubens, MD, PhD, director, Office for Prevention of Prematurity and Stillbirths at Childrens. With the help of the Gates Foundation we are establishing important partnerships with global organizations, such as UNICEF and the March of Dimes, to strengthen our efforts through collaboration. Its our goal to develop an internationally focused, comprehensive research program to fully understand what causes premature births, including those that result in stillbirths, and how to prevent them on a global level.

Rubens is developing an international scientific advisory committee made up of experts representing major health centers and organizations, who have a strong history of leadership and contribution to maternal, neonatal and child health issues within low, middle or high income countries. This committee will advise the
'/>"/>

Contact: Jennifer Seymour
jennifer.seymour@seattlechildrens.org
206-987-5207
Children's Hospital and Regional Medical Center of Seattle
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Researchers Aim to Prevent Global Prematurity and Stillbirths
2. UH researchers study Hispanic childrens activities, views on places to play
3. Researchers discover new way to reverse poor circulation and heal wounds
4. Bacterial toxin closes gate on immune response, Penn researchers discover
5. UD researchers discover technique for repairing gene defect that causes spinal muscular atrophy
6. Veterinary researchers study poultry virus as human cancer treatment
7. UD researchers discover promising technique for repairing gene that causes spinal muscular atrophy
8. Researchers at BMC find disability does not necessarily follow disease in living to old age
9. Oregon researchers discover a mechanism leading to cleft palate
10. Penn childhood obesity researchers panelists at AAAS Town Hall Event
11. Researchers at Pulmonary Associates to study airway bypass procedure for severe emphysema

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...ewswire-USNewswire/ -- Tonight, in a partisan vote...,s version of the government takeover of health ca... in this bill; like the public option, employer an...or elective abortion, which is the most onerous an...vides subsidies for private plans that cover elect...
(Date:11/21/2009)...ey Provisions of Legislation, Continues Push for P...Ill., Nov. 21 With th...rk Affordable Health Care for America Act (H.R. 39...lation forward, Congress has taken decisive steps ...day, AARP hosted an educational forum to discuss t...
(Date:11/21/2009)...ll, president and chief executive officer of the A...following statement regarding the inclusion of cog...ual wellness for Medicare beneficiaries in "T...; that was introduced last night: , ...-- Eric J. Hall, president and chief executive off...
(Date:11/20/2009)...Newswire-USNewswire/ -- The American Academy of A...re reform legislation released this week to contai...ndividual coverage mandate. The actuaries said tha...ze adverse selection stemming from more restrictiv..., "The individual mandate language should be st...
(Date:11/20/2009)...ire-USNewswire/ -- The American Dental Association...ration (FDA) to establish appropriate classificati...oncern about the safety of whitening products that...fessional consultation or examination by a dentist...mically based tooth whitening or bleaching agents ...
Breaking Medicine News(10 mins):Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...SOFT (OCuSOFT,Inc.), a company specializing in oph...lmologists and optometrists, is pleased to announc...., to its Optometric Scientific,Advisory Board. *...d to playing a key role in the center,s developmen...
...ograms and support services in Los ...Lupus Foundation of,America (LFA) and Maybelline(R...ly Foundation hosted the First Annual "Butterflies...than 300,celebrities and guests who helped raise f...
...Dental,Association (ADA) House of Delegates called...nderstand the materials used to create dental fill... ease of placement, durability,and relative costs ...her outlets, the,association wants to ensure its a...
...high Circumference, LAS VEGAS, Oct. 2 Ariana Cos... America to offer Syneron,s VelaShape, the only,FD...inimize cellulite.,VelaShape uses elos technology ...e by almost an inch. Dr. Michael Belfiore of Aria...
...rns based on prostate cancer biopsy were found to ...this measurement could help predict the risk of pr... research published in the October 3 issue of JAMA...umors) of the prostate based on the patterns of pr...
...rch announced the,findings of the latest wave of i...urvey was completed in late June and found that ju...erage are definitely or very likely,to switch to M... switch, general satisfaction with their current,c...
Other Medicine News:Health News:Stars Shine on 'Butterflies Over Hollywood' for Lupus Foundation of America 2Health News:ADA Calls for Scientifically Accurate Patient Brochure Explaining Filling Choices 2Health News:Ariana First to Offer VelaShape in North America 2Health News:Using additional biopsy-scoring data may help determine prostate cancer prognosis 2
(Date:11/20/2009)...0 Smith & Nephew ( S...nnounce the signing of a technology development co...e that may lead to the creation of a fracture fixa...t of the limbs of soldiers who sustain battlefield...esearch Projects Agency (DARPA), the central resea...
(Date:11/19/2009).... 19 BioCryst Pharmaceut...ricing of a public offering of 5,000,000 shares of... gross proceeds of $48.75 million. All of the sha...ffective shelf registration statement previously f... BioCryst has also granted the underwriters a 30-d...
(Date:11/19/2009)...ov. 19 /PRNewswire-Asia/ -- ScinoPharm, a leading ...ts (APIs), announced that its,Tainan facility has ...from,SafeBridge(R) Consultants, Inc. The Certifica...ncy in the safe handling of potent active,pharmace... laboratories and,production areas used for the ma...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 1Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 2Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 3Norman Brinker Honored With 2009 Methodist Health System Folsom Leadership Award 48569 4Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 1Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 2Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 3Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 1New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 2New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 3New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 4New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 5New Phase 3 Data Continue to Indicate that Wyeths Investigational 13 valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease 12578 6
...tive Disease Week(R) 2008, NATICK, Mass. and SAN ...: BSX ) today announced results from an,internati...vorable safety,and clinical utility data for its S...s extensive visual access to the biliary tract. Re...Chen, M.D., Division of Gastroenterology,& Hepatol...
...estive Disease Week -, CAMBRIDGE, Mass. and NEW Y...rly Microbia, Inc.) and Forest,Laboratories, Inc. ...data,from a Phase 2b randomized, double-blind, pla...icacy of linaclotide in patients with chronic,cons...t linaclotide met its,primary endpoint. The study ...
Other Medicine Technology:Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 2Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 3Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 4Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientific's SpyGlass(R) Direct Visualization System 5Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 2Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 3Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 4Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 5Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results 6
... The Portex® Thermovent® T helps provide p...y patient. It is small and extremely lightweight m...s adults. With a high rate of heat and moisture re...retion retention., ,All HMEs and filters have ISO...
... The Portex® Thermovent® T helps provide p...y patient. It is small and extremely lightweight m...s adults. With a high rate of heat and moisture re...retion retention., ,All HMEs and filters have ISO...
... The Portex® Thermovent® T helps provide p...y patient. It is small and extremely lightweight m...s adults. With a high rate of heat and moisture re...retion retention., ,All HMEs and filters have ISO...
Clear-Therm™ with Flextube
Medicine Products: